QSAR studies on 1-phenylbenzimidazoles as inhibitors of the platelet-derived growth factor

31Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This work is devoted to the development of quantitative structure-activity relationship (QSAR) models of the biological activity of 123 1-phenylbenzimidazoles as inhibitors of the PDGF receptor. The molecular features are represented by chemical descriptors that have been calculated on geometrical, topological, quantum mechanical, and electronic basis by using CODESSA PRO. The obtained models, linear (multilinear regression) and nonlinear (artificial neural network), are aimed to link the structures to their reported activity log 1/IC50. The former model can be used for physico-chemical interpretation, while the latter possesses a superior predictive ability. © 2005 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Katritzky, A. R., Dobchev, D. A., Fara, D. C., & Karelson, M. (2005). QSAR studies on 1-phenylbenzimidazoles as inhibitors of the platelet-derived growth factor. Bioorganic and Medicinal Chemistry, 13(24), 6598–6608. https://doi.org/10.1016/j.bmc.2005.06.067

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free